Rebiopsy for Patients with Non-Small Cell Lung Cancer after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Failure

被引：0
|
作者：
Li, Xuefei [1 ]
Su, Chunxia [2 ]
Ren, Shengxiang [2 ]
Zhao, Chao [1 ]
Jiang, Tao [1 ]
Zhou, Caicun [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
rebiopsy; non-small cell lung cancer; EGFR-TKI; EGFR mutation;
D O I：
10.1016/j.jtho.2016.11.1772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-104
引用
收藏
页码：S1256 / S1256
页数：1
相关论文
共 50 条
  • [31] Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review
    Imakita, Takuma
    Matsumoto, Hirotaka
    Hirano, Katsuya
    Morisawa, Toshiyuki
    Sakurai, Azusa
    Kataoka, Yuki
    [J]. BMC CANCER, 2019, 19 (1)
  • [32] Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review
    Takuma Imakita
    Hirotaka Matsumoto
    Katsuya Hirano
    Toshiyuki Morisawa
    Azusa Sakurai
    Yuki Kataoka
    [J]. BMC Cancer, 19
  • [33] Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer
    Yang, SH
    Mechanic, LE
    Yang, P
    Landi, MT
    Bowman, ED
    Wampfler, J
    Meerzaman, D
    Hong, KM
    Mann, F
    Dracheva, T
    Fukuoka, J
    Travis, W
    Caporaso, NE
    Harris, CC
    Jen, A
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2106 - 2110
  • [34] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
    Jamal-Hanjani, Mariam
    Spicer, James
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (04) : 938 - 944
  • [35] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
    Morin-Ben Abdallah, Sami
    Hirsh, Vera
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [36] Metformin Plus Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer
    Gao, Chan
    Cai, Shangli
    He, Yong
    [J]. JAMA ONCOLOGY, 2020, 6 (05) : 782 - 782
  • [37] PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN NON-SMALL CELL LUNG CANCER IN IRELAND
    Gorry, C.
    Connolly, E.
    Trela-Larsen, L.
    Barry, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S491 - S491
  • [38] Epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Dancey, Janet E.
    [J]. DRUGS, 2007, 67 (08) : 1125 - 1138
  • [39] TREATMENT OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
    Nanjo, S.
    Katakami, N.
    Otsuka, K.
    Tachikawa, R.
    Hata, A.
    Otsuka, K.
    Kaji, R.
    Fujita, S.
    Hayashi, M.
    Tomii, K.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 142 - 142
  • [40] Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a decade of progress and hopeful future
    Rajagopalan, Kumar
    Govindan, Ramaswamy
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 217 - 219
12345